[HTML][HTML] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced …
SM Cao, Q Yang, L Guo, HQ Mai, HY Mo… - European journal of …, 2017 - Elsevier
Background The role of neoadjuvant chemotherapy (NACT) for locoregionally advanced
nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the feasibility and …
nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the feasibility and …
[HTML][HTML] Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized …
PY OuYang, C Xie, YP Mao, Y Zhang, XX Liang, Z Su… - Annals of oncology, 2013 - Elsevier
Background We carried out this meta-analysis to demonstrate efficacies of neoadjuvant
chemotherapy (NACT) and adjuvant chemotherapy (AC) for nasopharyngeal carcinoma …
chemotherapy (NACT) and adjuvant chemotherapy (AC) for nasopharyngeal carcinoma …
An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features
Objectives We aimed to build a survival system by combining a highly-accurate machine
learning (ML) model with explainable artificial intelligence (AI) techniques to predict distant …
learning (ML) model with explainable artificial intelligence (AI) techniques to predict distant …
The best choice of induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma: bayesian network meta‐analysis
T Liu, S Dai, H Zhang, X Zhong, Z Ding, X Ma - Head & Neck, 2022 - Wiley Online Library
The determination of the optimal induction chemotherapy (IC) regimen for patients with
locally advanced nasopharyngeal carcinoma (NPC) remains controversial. Eligible trials …
locally advanced nasopharyngeal carcinoma (NPC) remains controversial. Eligible trials …
Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current …
G Numico, P Franco, A Cristofano, F Migliaccio… - Critical reviews in …, 2013 - Elsevier
The administration of Cetuximab in combination with radiotherapy and chemotherapy has
shown clear survival improvements within the locally advanced and the relapsed/metastatic …
shown clear survival improvements within the locally advanced and the relapsed/metastatic …
A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced …
T Xu, G Zhu, X He, H Ying, C Hu - Oral oncology, 2014 - Elsevier
Objective To determine whether concurrent chemoradiotherapy (CCRT) can improve
survival rates compared to the neoadjuvant chemotherapy (NACT) regimen in locoregionally …
survival rates compared to the neoadjuvant chemotherapy (NACT) regimen in locoregionally …
[HTML][HTML] Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A …
PS Pai, AD Vaidya, K Prabhash… - Indian journal of …, 2013 - journals.lww.com
AIM: We evaluated oral metronomic scheduling of anticancer therapy (MSAT) in advanced
operable oral cancers, in conjunction with standard therapy. SETTINGS AND DESIGN: This …
operable oral cancers, in conjunction with standard therapy. SETTINGS AND DESIGN: This …
Overexpression of CD 147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells
Z Huang, L Wang, Y Wang, Y Zhuo, H Li… - Journal of oral …, 2013 - Wiley Online Library
Head and neck cancer is the sixth most common cancer in the world and most of them are
squamous cell carcinomas. High frequency of cisplatin resistance in head and neck …
squamous cell carcinomas. High frequency of cisplatin resistance in head and neck …
[HTML][HTML] Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model
W Liu, B Yu, Y Luo, J Li, X Yuan, S Wu, B Liang, Z Lv… - BMC cancer, 2021 - Springer
Abstract Background Although the National Comprehensive Cancer Network (NCCN)
Guidelines recommend CCRT+ AC and IC+ CCRT as level 2A evidence for treatment of the …
Guidelines recommend CCRT+ AC and IC+ CCRT as level 2A evidence for treatment of the …
[HTML][HTML] Prognostic and treatment guiding significance of MRI-based tumor burden features and nodal necrosis in nasopharyngeal carcinoma
X Chen, X Cao, B Jing, W Xia, L Ke, Y Xiang… - Frontiers in …, 2020 - frontiersin.org
We aimed to develop a nomogram integrating MRI-based tumor burden features (MTBF),
nodal necrosis, and some clinical factors to forecast the distant metastasis-free survival …
nodal necrosis, and some clinical factors to forecast the distant metastasis-free survival …